The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series A | Alive

Total Raised


Last Raised

$13.06M | 2 mos ago

About Boostimmune

Boostimmune researches and develops anticancer drugs that treat cancer by regulating the immune system. The company specializes in immuno-oncology drugs and antibody-drug conjugates that target myeloid. It was founded in 2021 and is based in Seoul, South Korea.

Boostimmune Headquarter Location

6F 36, Nambuhwan-ro 350-gil, Seocho-gu


South Korea

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • When was Boostimmune founded?

    Boostimmune was founded in 2021.

  • Where is Boostimmune's headquarters?

    Boostimmune's headquarters is located at 6F, Seoul.

  • What is Boostimmune's latest funding round?

    Boostimmune's latest funding round is Series A.

  • How much did Boostimmune raise?

    Boostimmune raised a total of $14.8M.

  • Who are the investors of Boostimmune?

    Investors of Boostimmune include Smilegate Investment, Mirae Asset Financial Group, AJU IB Investment, Company K Partners, TIMEFOLIO Asset Management and 6 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.